Alpha Wave Global is a New York City-based investment firm that operates across three main verticals: private equity, private credit, and public markets. The firm typically engages in various stages of investment, including Series A, Series B, Series C, and beyond, as well as seed and private equity rounds. Their investment amounts vary significantly, reflecting their broad focus on different stages of company growth.
Notable portfolio companies include Amylyx Pharmaceuticals, Apnimed, Athletic Greens, and Lenskart. Key partners at Alpha Wave Global include Rick Gerson, Navroz D. Udwadia, Ryan Khoury, and Matthew Corey. The firm emphasizes a collaborative investment philosophy and offers unique value-add services to its portfolio companies, leveraging the extensive expertise of its leadership team to drive growth and innovation.
Alpha Wave Global - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Total Investments32
Current Portfolio Count27
Total Portfolio Exits0
Top Investment Stages
Series B11 (40.7%)
Series A6 (22.2%)
Series C5 (18.5%)
Series Unknown3 (11.1%)
Private Equity2 (7.4%)
Stage Mix
Series B 41%Series A 22%Series C 19%Series Unknown 11%Private Equity 7%
Concentration shown as share of disclosed investments by stage.
Alpha Wave Global - Classification
- Also Known As
- Alpha Wave Global LP.
- NAICS
- 520000Finance and Insurance
- 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
- 523900Other Financial Investment Activities
- 523990All Other Financial Investment Activities
- 523999Miscellaneous Financial Investment Activities
- SIC
- 6700Holding And Other Investment Offices
- 6720Investment Offices
- 6722Management Investment Offices, Open-end
Show 5 more industry codes
- NAICS
- 525000Funds, Trusts, and Other Financial Vehicles
- 523940Portfolio Management and Investment Advice
- SIC
- 6000Depository Institutions
- 6790Miscellaneous Investing
- 6799Investors, Not Elsewhere Classified